Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
St. Jude Children's Research Hospital
City of Hope Medical Center
Fred Hutchinson Cancer Center
Hospital General de Mexico
Masonic Cancer Center, University of Minnesota
First Affiliated Hospital of Zhejiang University